🇺🇸 FDA

Company profile · Sponsor

Monopar

Monopar Therapeutics

MNPR · NYSE pharma WILMETTE, IL, USA
Pipeline
4
Drugs
0
Patents
3

Quick answer

Monopar (MNPR) is a pharma company. headquartered in WILMETTE, IL, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 3 patents to this profile..

Company facts

Ticker MNPR
Exchange NYSE
Company type pharma
Headquarters WILMETTE, IL, USA
SEC CIK 0001645469

Pipeline (4)

Search pipeline →

  1. Clonidine HCl Mucoadhesive Buccal Tablet

    Monopar

    Chemoradiotherapy-Induced Severe Oral Mucositis

    phase 3 small molecule terminated

    1 trial

  2. Camsirubicin

    Monopar

    Advanced Soft-tissue Sarcoma

    phase 1 small molecule terminated

    1 trial

  3. MNPR-101-DFO*-89Zr

    Monopar

    Solid Tumor, Adult

    phase 1 small molecule active

    1 trial

  4. MNPR-101-PCTA-177Lu

    Monopar

    Solid Tumor, Adult

    phase 1 small molecule active

    1 trial

Patents (3)

Search patents →

  1. US 11090290

    Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10675271

    Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10450340

    3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of preparation

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Monopar?

Monopar (MNPR) is a pharma company. headquartered in WILMETTE, IL, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 3 patents to this profile..

What pipeline programs does Monopar sponsor?

We track 4 ClinicalTrials.gov-linked programs for Monopar, including Clonidine HCl Mucoadhesive Buccal Tablet and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Monopar company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.